Table of Content



1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Rabies Vaccine
1.2 Key Market Segments
1.2.1 Human Rabies Vaccine Segment by Type
1.2.2 Human Rabies Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats

2 Human Rabies Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Human Rabies Vaccine Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Human Rabies Vaccine Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 Human Rabies Vaccine Market Competitive Landscape
3.1 Global Human Rabies Vaccine Sales by Manufacturers (2017-2022)
3.2 Global Human Rabies Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.3 Human Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Rabies Vaccine Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Human Rabies Vaccine Sales Sites, Area Served, Product Type
3.6 Human Rabies Vaccine Market Competitive Situation and Trends
3.6.1 Human Rabies Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Rabies Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion

4 Human Rabies Vaccine Industry Chain Analysis
4.1 Human Rabies Vaccine Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 The Development and Dynamics of Human Rabies Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 Human Rabies Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Rabies Vaccine Sales Market Share by Type (2017-2022)
6.3 Global Human Rabies Vaccine Market Size Market Share by Type (2017-2022)
6.4 Global Human Rabies Vaccine Price by Type (2017-2022)

7 Human Rabies Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Rabies Vaccine Market Sales by Application (2017-2022)
7.3 Global Human Rabies Vaccine Market Size (M USD) by Application (2017-2022)
7.4 Global Human Rabies Vaccine Sales Growth Rate by Application (2017-2022)

8 Human Rabies Vaccine Market Segmentation by Region
8.1 Global Human Rabies Vaccine Sales by Region
8.1.1 Global Human Rabies Vaccine Sales by Region
8.1.2 Global Human Rabies Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Human Rabies Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Rabies Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Rabies Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Rabies Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Rabies Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa

9 Key Companies Profiled
9.1 Bharat Biotech
9.1.1 Bharat Biotech Human Rabies Vaccine Basic Information
9.1.2 Bharat Biotech Human Rabies Vaccine Product Overview
9.1.3 Bharat Biotech Human Rabies Vaccine Product Market Performance
9.1.4 Bharat Biotech Business Overview
9.1.5 Bharat Biotech Human Rabies Vaccine SWOT Analysis
9.1.6 Bharat Biotech Recent Developments
9.2 Bavarian Nordic
9.2.1 Bavarian Nordic Human Rabies Vaccine Basic Information
9.2.2 Bavarian Nordic Human Rabies Vaccine Product Overview
9.2.3 Bavarian Nordic Human Rabies Vaccine Product Market Performance
9.2.4 Bavarian Nordic Business Overview
9.2.5 Bavarian Nordic Human Rabies Vaccine SWOT Analysis
9.2.6 Bavarian Nordic Recent Developments
9.3 Sanofi-Pasteur
9.3.1 Sanofi-Pasteur Human Rabies Vaccine Basic Information
9.3.2 Sanofi-Pasteur Human Rabies Vaccine Product Overview
9.3.3 Sanofi-Pasteur Human Rabies Vaccine Product Market Performance
9.3.4 Sanofi-Pasteur Business Overview
9.3.5 Sanofi-Pasteur Human Rabies Vaccine SWOT Analysis
9.3.6 Sanofi-Pasteur Recent Developments
9.4 Chengda Bio
9.4.1 Chengda Bio Human Rabies Vaccine Basic Information
9.4.2 Chengda Bio Human Rabies Vaccine Product Overview
9.4.3 Chengda Bio Human Rabies Vaccine Product Market Performance
9.4.4 Chengda Bio Business Overview
9.4.5 Chengda Bio Human Rabies Vaccine SWOT Analysis
9.4.6 Chengda Bio Recent Developments
9.5 KANGH
9.5.1 KANGH Human Rabies Vaccine Basic Information
9.5.2 KANGH Human Rabies Vaccine Product Overview
9.5.3 KANGH Human Rabies Vaccine Product Market Performance
9.5.4 KANGH Business Overview
9.5.5 KANGH Human Rabies Vaccine SWOT Analysis
9.5.6 KANGH Recent Developments
9.6 Prcmise
9.6.1 Prcmise Human Rabies Vaccine Basic Information
9.6.2 Prcmise Human Rabies Vaccine Product Overview
9.6.3 Prcmise Human Rabies Vaccine Product Market Performance
9.6.4 Prcmise Business Overview
9.6.5 Prcmise Recent Developments
9.7 Henan Grand Biopharma
9.7.1 Henan Grand Biopharma Human Rabies Vaccine Basic Information
9.7.2 Henan Grand Biopharma Human Rabies Vaccine Product Overview
9.7.3 Henan Grand Biopharma Human Rabies Vaccine Product Market Performance
9.7.4 Henan Grand Biopharma Business Overview
9.7.5 Henan Grand Biopharma Recent Developments
9.8 Zhuoyi Biological
9.8.1 Zhuoyi Biological Human Rabies Vaccine Basic Information
9.8.2 Zhuoyi Biological Human Rabies Vaccine Product Overview
9.8.3 Zhuoyi Biological Human Rabies Vaccine Product Market Performance
9.8.4 Zhuoyi Biological Business Overview
9.8.5 Zhuoyi Biological Recent Developments
9.9 ZhongKe Biopharm
9.9.1 ZhongKe Biopharm Human Rabies Vaccine Basic Information
9.9.2 ZhongKe Biopharm Human Rabies Vaccine Product Overview
9.9.3 ZhongKe Biopharm Human Rabies Vaccine Product Market Performance
9.9.4 ZhongKe Biopharm Business Overview
9.9.5 ZhongKe Biopharm Recent Developments
9.10 Ningbo Rongan Biological
9.10.1 Ningbo Rongan Biological Human Rabies Vaccine Basic Information
9.10.2 Ningbo Rongan Biological Human Rabies Vaccine Product Overview
9.10.3 Ningbo Rongan Biological Human Rabies Vaccine Product Market Performance
9.10.4 Ningbo Rongan Biological Business Overview
9.10.5 Ningbo Rongan Biological Recent Developments
9.11 Indian Immunologicals
9.11.1 Indian Immunologicals Human Rabies Vaccine Basic Information
9.11.2 Indian Immunologicals Human Rabies Vaccine Product Overview
9.11.3 Indian Immunologicals Human Rabies Vaccine Product Market Performance
9.11.4 Indian Immunologicals Business Overview
9.11.5 Indian Immunologicals Recent Developments
10 Human Rabies Vaccine Market Forecast by Region
10.1 Global Human Rabies Vaccine Market Size Forecast
10.2 Global Human Rabies Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Rabies Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Human Rabies Vaccine Market Size Forecast by Region
10.2.4 South America Human Rabies Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Rabies Vaccine by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Human Rabies Vaccine Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Human Rabies Vaccine by Type (2022-2028)
11.1.2 Global Human Rabies Vaccine Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Human Rabies Vaccine by Type (2022-2028)
11.2 Global Human Rabies Vaccine Market Forecast by Application (2022-2028)
11.2.1 Global Human Rabies Vaccine Sales (K Units) Forecast by Application
11.2.2 Global Human Rabies Vaccine Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings



List of Figures

?LIST OF TABLES

Table 1. Introduction of the Type

Table 2. Introduction of the Application

Table 3. Market Size (M USD) Segment Executive Summary

Table 4. Human Rabies Vaccine Market Size (M USD) Comparison by Region (M USD)

Table 5. Global Human Rabies Vaccine Sales (K Units) by Manufacturers (2017-2022)

Table 6. Global Human Rabies Vaccine Sales Market Share by Manufacturers (2017-2022)

Table 7. Global Human Rabies Vaccine Revenue (M USD) by Manufacturers (2017-2022)

Table 8. Global Human Rabies Vaccine Revenue Share by Manufacturers (2017-2022)

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Vaccine as of 2021)

Table 10. Global Market Human Rabies Vaccine Average Price (USD/Unit) of Key Manufacturers (2017-2022)

Table 11. Manufacturers Human Rabies Vaccine Sales Sites and Area Served

Table 12. Manufacturers Human Rabies Vaccine Product Type

Table 13. Global Human Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Mergers & Acquisitions, Expansion Plans

Table 15. Industry Chain Map of Human Rabies Vaccine

Table 16. Raw Materials

Table 17. Midstream Market Analysis

Table 18. Downstream Customer Analysis

Table 19. Key Development Trends

Table 20. Driving Factors

Table 21. Human Rabies Vaccine Market Challenges

Table 22. Market Restraints

Table 23. Global Human Rabies Vaccine Sales by Type (K Units)

Table 24. Global Human Rabies Vaccine Market Size by Type (M USD)

Table 25. Global Human Rabies Vaccine Sales (K Units) by Type (2017-2022)

Table 26. Global Human Rabies Vaccine Sales Market Share by Type (2017-2022)

Table 27. Global Human Rabies Vaccine Market Size (M USD) by Type (2017-2022)

Table 28. Global Human Rabies Vaccine Market Size Share by Type (2017-2022)

Table 29. Global Human Rabies Vaccine Price (USD/Unit) by Type (2017-2022)

Table 30. Global Human Rabies Vaccine Sales (K Units) by Application

Table 31. Global Human Rabies Vaccine Market Size by Application

Table 32. Global Human Rabies Vaccine Sales by Application (2017-2022) & (K Units)

Table 33. Global Human Rabies Vaccine Sales Market Share by Application (2017-2022)

Table 34. Global Human Rabies Vaccine Sales by Application (2017-2022) & (M USD)

Table 35. Global Human Rabies Vaccine Market Share by Application (2017-2022)

Table 36. Global Human Rabies Vaccine Sales Growth Rate by Application (2017-2022)

Table 37. Global Human Rabies Vaccine Sales by Region (2017-2022) & (K Units)

Table 38. Global Human Rabies Vaccine Sales Market Share by Region (2017-2022)

Table 39. North America Human Rabies Vaccine Sales by Country (2017-2022) & (K Units)

Table 40. Europe Human Rabies Vaccine Sales by Country (2017-2022) & (K Units)

Table 41. Asia Pacific Human Rabies Vaccine Sales by Region (2017-2022) & (K Units)

Table 42. South America Human Rabies Vaccine Sales by Country (2017-2022) & (K Units)

Table 43. Middle East and Africa Human Rabies Vaccine Sales by Region (2017-2022) & (K Units)

Table 44. Bharat Biotech Human Rabies Vaccine Basic Information

Table 45. Bharat Biotech Human Rabies Vaccine Product Overview

Table 46. Bharat Biotech Human Rabies Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 47. Bharat Biotech Business Overview

Table 48. Bharat Biotech Human Rabies Vaccine SWOT Analysis

Table 49. Bharat Biotech Recent Developments

Table 50. Bavarian Nordic Human Rabies Vaccine Basic Information

Table 51. Bavarian Nordic Human Rabies Vaccine Product Overview

Table 52. Bavarian Nordic Human Rabies Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 53. Bavarian Nordic Business Overview

Table 54. Bavarian Nordic Human Rabies Vaccine SWOT Analysis

Table 55. Bavarian Nordic Recent Developments

Table 56. Sanofi-Pasteur Human Rabies Vaccine Basic Information

Table 57. Sanofi-Pasteur Human Rabies Vaccine Product Overview

Table 58. Sanofi-Pasteur Human Rabies Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 59. Sanofi-Pasteur Business Overview

Table 60. Sanofi-Pasteur Human Rabies Vaccine SWOT Analysis

Table 61. Sanofi-Pasteur Recent Developments

Table 62. Chengda Bio Human Rabies Vaccine Basic Information

Table 63. Chengda Bio Human Rabies Vaccine Product Overview

Table 64. Chengda Bio Human Rabies Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 65. Chengda Bio Business Overview

Table 66. Chengda Bio Human Rabies Vaccine SWOT Analysis

Table 67. Chengda Bio Recent Developments

Table 68. KANGH Human Rabies Vaccine Basic Information

Table 69. KANGH Human Rabies Vaccine Product Overview

Table 70. KANGH Human Rabies Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 71. KANGH Business Overview

Table 72. KANGH Human Rabies Vaccine SWOT Analysis

Table 73. KANGH Recent Developments

Table 74. Prcmise Human Rabies Vaccine Basic Information

Table 75. Prcmise Human Rabies Vaccine Product Overview

Table 76. Prcmise Human Rabies Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 77. Prcmise Business Overview

Table 78. Prcmise Recent Developments

Table 79. Henan Grand Biopharma Human Rabies Vaccine Basic Information

Table 80. Henan Grand Biopharma Human Rabies Vaccine Product Overview

Table 81. Henan Grand Biopharma Human Rabies Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 82. Henan Grand Biopharma Business Overview

Table 83. Henan Grand Biopharma Recent Developments

Table 84. Zhuoyi Biological Human Rabies Vaccine Basic Information

Table 85. Zhuoyi Biological Human Rabies Vaccine Product Overview

Table 86. Zhuoyi Biological Human Rabies Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 87. Zhuoyi Biological Business Overview

Table 88. Zhuoyi Biological Recent Developments

Table 89. ZhongKe Biopharm Human Rabies Vaccine Basic Information

Table 90. ZhongKe Biopharm Human Rabies Vaccine Product Overview

Table 91. ZhongKe Biopharm Human Rabies Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 92. ZhongKe Biopharm Business Overview

Table 93. ZhongKe Biopharm Recent Developments

Table 94. Ningbo Rongan Biological Human Rabies Vaccine Basic Information

Table 95. Ningbo Rongan Biological Human Rabies Vaccine Product Overview

Table 96. Ningbo Rongan Biological Human Rabies Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 97. Ningbo Rongan Biological Business Overview

Table 98. Ningbo Rongan Biological Recent Developments

Table 99. Indian Immunologicals Human Rabies Vaccine Basic Information

Table 100. Indian Immunologicals Human Rabies Vaccine Product Overview

Table 101. Indian Immunologicals Human Rabies Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 102. Indian Immunologicals Business Overview

Table 103. Indian Immunologicals Recent Developments

Table 104. Global Human Rabies Vaccine Sales Forecast by Region (K Units)

Table 105. Global Human Rabies Vaccine Market Size Forecast by Region (M USD)

Table 106. North America Human Rabies Vaccine Sales Forecast by Country (2022-2028) & (K Units)

Table 107. North America Human Rabies Vaccine Market Size Forecast by Country (2022-2028) & (M USD)

Table 108. Europe Human Rabies Vaccine Sales Forecast by Country (2022-2028) & (K Units)

Table 109. Europe Human Rabies Vaccine Market Size Forecast by Country (2022-2028) & (M USD)

Table 110. Asia Pacific Human Rabies Vaccine Sales Forecast by Region (2022-2028) & (K Units)

Table 111. Asia Pacific Human Rabies Vaccine Market Size Forecast by Region (2022-2028) & (M USD)

Table 112. South America Human Rabies Vaccine Sales Forecast by Country (2022-2028) & (K Units)

Table 113. South America Human Rabies Vaccine Market Size Forecast by Country (2022-2028) & (M USD)

Table 114. Middle East and Africa Human Rabies Vaccine Consumption Forecast by Country (2022-2028) & (Units)

Table 115. Middle East and Africa Human Rabies Vaccine Market Size Forecast by Country (2022-2028) & (M USD)

Table 116. Global Human Rabies Vaccine Sales Forecast by Type (2022-2028) & (K Units)

Table 117. Global Human Rabies Vaccine Market Size Forecast by Type (2022-2028) & (M USD)

Table 118. Global Human Rabies Vaccine Price Forecast by Type (2022-2028) & (USD/Unit)

Table 119. Global Human Rabies Vaccine Sales (K Units) Forecast by Application (2022-2028)

Table 120. Global Human Rabies Vaccine Market Size Forecast by Application (2022-2028) & (M USD)

List of Figures

Figure 1. Product Picture of Human Rabies Vaccine

Figure 2. Data Triangulation

Figure 3. Key Caveats

Figure 4. Global Human Rabies Vaccine Market Size (M USD), 2017-2028

Figure 5. Global Human Rabies Vaccine Market Size (M USD) (2017-2028)

Figure 6. Global Human Rabies Vaccine Sales (K Units) & (2017-2028)

Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)

Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)

Figure 9. Evaluation Matrix of Regional Market Development Potential

Figure 10. Human Rabies Vaccine Market Size (M USD) by Country (M USD)

Figure 11. Human Rabies Vaccine Sales Share by Manufacturers in 2020

Figure 12. Global Human Rabies Vaccine Revenue Share by Manufacturers in 2020

Figure 13. Human Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

Figure 14. Global Market Human Rabies Vaccine Average Price (USD/Unit) of Key Manufacturers in 2020

Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Rabies Vaccine Revenue in 2021

Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)

Figure 17. Global Human Rabies Vaccine Market Share by Type

Figure 18. Sales Market Share of Human Rabies Vaccine by Type (2017-2022)

Figure 19. Sales Market Share of Human Rabies Vaccine by Type in 2021

Figure 20. Market Size Share of Human Rabies Vaccine by Type (2017-2022)

Figure 21. Market Size Market Share of Human Rabies Vaccine by Type in 2020

Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)

Figure 23. Global Human Rabies Vaccine Market Share by Application

Figure 24. Global Human Rabies Vaccine Sales Market Share by Application (2017-2022)

Figure 25. Global Human Rabies Vaccine Sales Market Share by Application in 2021

Figure 26. Global Human Rabies Vaccine Market Share by Application (2017-2022)

Figure 27. Global Human Rabies Vaccine Market Share by Application in 2020

Figure 28. Global Human Rabies Vaccine Sales Growth Rate by Application (2017-2022)

Figure 29. Global Human Rabies Vaccine Sales Market Share by Region (2017-2022)

Figure 30. North America Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 31. North America Human Rabies Vaccine Sales Market Share by Country in 2020

Figure 32. U.S. Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 33. Canada Human Rabies Vaccine Sales (K Units) and Growth Rate (2017-2022)

Figure 34. Mexico Human Rabies Vaccine Sales (Units) and Growth Rate (2017-2022)

Figure 35. Europe Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 36. Europe Human Rabies Vaccine Sales Market Share by Country in 2020

Figure 37. Germany Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 38. France Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 39. U.K. Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 40. Italy Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 41. Russia Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 42. Asia Pacific Human Rabies Vaccine Sales and Growth Rate (K Units)

Figure 43. Asia Pacific Human Rabies Vaccine Sales Market Share by Region in 2020

Figure 44. China Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 45. Japan Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 46. South Korea Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 47. India Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 48. Southeast Asia Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 49. South America Human Rabies Vaccine Sales and Growth Rate (K Units)

Figure 50. South America Human Rabies Vaccine Sales Market Share by Country in 2020

Figure 51. Brazil Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 52. Argentina Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 53. Columbia Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 54. Middle East and Africa Human Rabies Vaccine Sales and Growth Rate (K Units)

Figure 55. Middle East and Africa Human Rabies Vaccine Sales Market Share by Region in 2020

Figure 56. Saudi Arabia Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 57. UAE Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 58. Egypt Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 59. Nigeria Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 60. South Africa Human Rabies Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 61. Global Human Rabies Vaccine Sales Forecast by Volume (2017-2028) & (K Units)

Figure 62. Global Human Rabies Vaccine Market Size Forecast by Value (2017-2028) & (M USD)

Figure 63. Global Human Rabies Vaccine Sales Market Share Forecast by Type (2022-2028)

Figure 64. Global Human Rabies Vaccine Market Share Forecast by Type (2022-2028)

Figure 65. Global Human Rabies Vaccine Sales Forecast by Application (2022-2028)

Figure 66. Global Human Rabies Vaccine Market Share Forecast by Application (2022-2028)